These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30176263)

  • 1. Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.
    Barone I; Vircillo V; Giordano C; Gelsomino L; Győrffy B; Tarallo R; Rinaldi A; Bruno G; Caruso A; Romeo F; Bonofiglio D; Andò S; Catalano S
    Cancer Lett; 2018 Nov; 437():89-99. PubMed ID: 30176263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
    Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
    Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
    Dvorak KM; Pettee KM; Rubinic-Minotti K; Su R; Nestor-Kalinoski A; Eisenmann KM
    PLoS One; 2018; 13(3):e0195278. PubMed ID: 29596520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE; Korbonits M; Carpenter R; Walsh DT; Warner TD; Bishop-Bailey D
    Cancer Res; 2006 Oct; 66(20):10120-6. PubMed ID: 17047076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
    Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
    Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors.
    Singh N; Yadav M; Singh AK; Kumar H; Dwivedi SK; Mishra JS; Gurjar A; Manhas A; Chandra S; Yadav PN; Jagavelu K; Siddiqi MI; Trivedi AK; Chattopadhyay N; Sanyal S
    Mol Endocrinol; 2014 May; 28(5):659-73. PubMed ID: 24597548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
    Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
    J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts.
    Angelucci C; Maulucci G; Colabianchi A; Iacopino F; D'Alessio A; Maiorana A; Palmieri V; Papi M; De Spirito M; Di Leone A; Masetti R; Sica G
    Br J Cancer; 2015 May; 112(10):1675-86. PubMed ID: 25880005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
    Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer.
    Chatterjee A; Jana S; Chatterjee S; Wastall LM; Mandal G; Nargis N; Roy H; Hughes TA; Bhattacharyya A
    Br J Cancer; 2019 Oct; 121(8):679-689. PubMed ID: 31481734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties.
    Flesch D; Gabler M; Lill A; Gomez RC; Steri R; Schneider G; Stark H; Schubert-Zsilavecz M; Merk D
    Bioorg Med Chem; 2015 Jul; 23(13):3490-8. PubMed ID: 25934227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.
    Lee JY; Lee KT; Lee JK; Lee KH; Jang KT; Heo JS; Choi SH; Kim Y; Rhee JC
    Br J Cancer; 2011 Mar; 104(6):1027-37. PubMed ID: 21364590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
    Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.